{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-003836","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.318712+00:00","generated_at":"2026-05-19T12:54:36.168204+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Predictive Oncology receives Nasdaq delisting notice for failure to meet equity requirement","bullets":["Nasdaq notified Predictive Oncology June 9 of delisting for failing to meet $2.5M stockholders' equity requirement.","Company could not complete compliance plan within 180-day extension granted by Nasdaq.","Trading suspended June 18 unless appeal requested by June 16; company appealed to Nasdaq Hearings Panel.","Appeal stays suspension; Panel may grant exception up to 180 days.","No assurance of continued listing; company evaluating all options."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-003836","json":"https://secwatch.observer/filing/0001171843-25-003836.json","markdown":"https://secwatch.observer/filing/0001171843-25-003836.md","text":"https://secwatch.observer/filing/0001171843-25-003836.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325003836/0001171843-25-003836-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325003836/f8k_061125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T12:54:36.168204+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d6bb32db11c8bae821264f68be90fb4db1d8837","claim":"Axe Compute Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"June 9, 2025, Predictive Oncology Inc. (the “Company”) received a letter (the “Notice) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because the Company had not regained compliance with the minimum $2,500,000 stockholders’ equity requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”), the Staff has determined to delist the Company’s securities from The Nasdaq Capital Market. The Company was unable to complete its previou","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325003836/0001171843-25-003836-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}